Mark Bolton, Radiation Oncologist, shared a post on X:
“SKAGEN-1
Breast cancer specific mortality HR 1.44 (1.05-1.97) in favor of 25 fx rather than 15 fx!!
Less trips to the clinic vs survival benefit – not a difficult choice, is it folks? ”
More posts featuring Breast Cancer on OncoDaily.